Wolfgang Brysch

This inventor holds 12 USPTO granted patents and 15 published patent applications, plus 5 CIPO patents and 17 EPO patents. Top assignees: Metriopharm Ag, Athenion Ag, Id Care Ug (Haftungsbeschränkt). Active years: 2014-2026.

USPTO Granted Patents = 12 (Patent Applications = 15)

% Patents Active = 91.7

CIPO Patents = 5 (Patent Applications = 13)

EPO Patents = 17 (Patent Applications = 24)

Average Co-Inventor Count = 4.1

ph-index = 1

Forward Citations = 6(Granted Patents)

Company Filing History:

Id Care Ug (Haftungsbeschränkt)

Years Active: 2014-2026

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12616695 - Use of 5-amino-2,3-dihydro-1,4-phthalazinedione in the treatment of rare chronic inflammatory pulmonary diseases (2026-05-05),

2. 12533416 - Krill oil for solubilizing poorly water-soluble dietary supplements and pharmaceutically active agents (2026-01-27),

3. 12122753 - Method for solubilizing 5-amino-2,3-dihydro-1,4-phthalazinedione (2024-10-22),

4. 11497760 - Method for solubilizing poorly water-soluble dietary supplements and pharmaceutically active agents (2022-11-15),

5. 11207256 - Method for solubilizing poorly water-soluble cosmetic agents (2021-12-28),

6. 11203575 - Methhod for producing a crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-dione (2021-12-21),

7. 11111218 - Crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-dione (2021-09-07),

8. 11007192 - Use of 5-amino-2,3-dihydro-1,4-phthalazinedione in the treatment of chronic progressive multiple sclerosis (2021-05-18),

9. 10588896 - Agents for the treatment of retroviral infectious diseases (2020-03-17),

10. 10258620 - Crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt, pharmaceutical preparations containing the same and method for the production of said form (2019-04-16),

11. 9079863 - Crystalline forms for 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt, pharmaceutical preparations containing the same and method for the production of said forms (2015-07-14),

12. 8772294 - Crystalline forms for 5-amino-2, 3-dihydrophthalazine-1, 4-dione sodium salt, pharmaceutical preparations containing the same and method for the production of said forms (2014-07-08),

Title: Wolfgang Brysch: Innovator in Pharmaceutical Solubilization

Introduction

Wolfgang Brysch is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceutical sciences, particularly in the area of solubilization methods for poorly soluble compounds. With a total of 12 patents to his name, Brysch's work has had a considerable impact on the development of effective pharmaceutical formulations.

Latest Patents

Among his latest patents, Brysch has developed a method for solubilizing 5-amino-2,3-dihydro-1,4-phthalazinedione. This invention relates to a method for solubilizing this compound or its salts, producing a solubilisate that can be utilized in pharmaceutical dosage forms. The method employs a phosphatidylcholine-based solubilization technique. Additionally, he has patented a method for solubilizing poorly water-soluble dietary supplements and pharmaceutically active agents. This invention also utilizes a phosphatidylcholine-based solubilization method, enhancing the bioavailability of these compounds in dietary and pharmaceutical applications.

Career Highlights

Throughout his career, Wolfgang Brysch has worked with several prominent companies, including Metriopharm AG and Athenion AG. His experience in these organizations has allowed him to refine his expertise in pharmaceutical formulations and solubilization techniques.

Collaborations

Brysch has collaborated with notable professionals in his field, including Jörg Von Wegerer and Thomas Martin. These collaborations have contributed to the advancement of his research and the successful development of his patented methods.

Conclusion

Wolfgang Brysch's innovative approaches to solubilization in pharmaceuticals demonstrate his commitment to improving drug delivery systems. His contributions continue to influence the industry and enhance the effectiveness of various pharmaceutical products.